This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 High-Paying Dividend Stocks For The Income Investor

So far in 2013 the Dow Jones Industrial Average (DJI) is up 15.1%. This could suggest challenges ahead as the second half of the year commences – as any further gains could put into question the sustainability of double-digit returns. In the absence of high interest rates, income-paying stocks become an increasingly attractive investment.

[Read more from Kapitall on the Dow Jones here.]

On the Dow Jones, four companies with the highest dividend yield might still attract investors. Note that telecom companies pay the highest yield, while pharmaceuticals are the most expensive when the Price to Sales ratio is used:

Screen shot 2013-07-01 at 12.43.46 PM

AT&T (T) has a forward yield of 5.07%. The company was added to Goldman Sachs’ list of favorite dividend investments with unusually high volatility. AT&T had wanted to build a position in Telefonica (TEF) , a Spanish telecom firm, but ultimately did not recevie the blessing of the Spanish government.

The company's prepaid plans have seen b etter network access, and 4G support was given to the GoPhone plans. This should give customers more options and greater value for service.

Click on the images below to see performance data and ratings over time. Data  sourced from Zacks Investment Research.

Verizon Communications (VZ) is also on Goldman Sachs’ dividend list. Shares pay a dividend that yields 4.1%. Verizon Wireless completed the rollout of 4G LTE, and claims the service is now available to 95% of the U.S. population. The company is reportedly entering the Canadian markets to grow. For a bid of around $700 million, Verizon is offering to buy Wind Mobile. The Canadian market is in need for greater competition, as consumers often have to sign up for a 3-year plan before smartphones are subsidized at a reasonable price.

In the pharmaceutical space, Johnson & Johnson​ (JNJ) offers a dividend yielding 3.1%. JNJ broke past a long time range of around $70 at the beginning of 2013:

But recent developments among some of the company's prescription drugs have not brought good news. In early June, the company issued a recall for 32 million packages of Cilest , a birth control pill. Two of the hormones were released more slowly than it was supposed to. Razadyne , which is used to treat Alzheimer’s, could have the side benefit of reducing the risk of heart attacks and death.

The other  pharmaceutical stock on our radar is  Pfizer (PFE), and the company's shares have a dividend that yields 3.4%. Currently, the company is buying back $10 billion in shares. This is on top of the $3.9 billion that remains under the current buyback plan.

Analyze These Ideas: Access a performance overview for all stocks in this article. 


Written by Chris Lau, Kapitall Contributor

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.69 -0.59%
FB $119.49 1.40%
GOOG $711.11 1.40%
TSLA $214.84 1.60%
YHOO $37.23 0.79%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs